Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS)

CAPS Rating: 1 out of 5

The Company is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel small molecule therapeutics for oncology and other unmet medical needs.

Recs

0
Player Avatar pchop123 (76.64) Submitted: 7/8/2012 10:57:01 PM : Outperform Start Price: $3.38 SNSS Score: -5.67

promise of more upside

Featured Broker Partners


Advertisement